IBRX CIK: 1326110

ImmunityBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−274
FY22:
−338
FY23:
−367
FY24:
−391
FY25:
−305
Change from FY21 to FY25
millions USD
FY21:
−84.9
FY22:
27.3
FY23:
−30.5
FY24:
−12.2
FY25:
−150
Change from FY21 to FY25
millions USD
FY21:
505
FY22:
234
FY23:
558
FY24:
282
FY25:
400
millions USD
FY21:
146
FY22:
−76.3
FY23:
161
FY24:
−122
FY25:
−54.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−308
FY22:
−416
FY23:
−397
FY24:
−398
FY25:
−309

All amounts in millions USD Data source:SEC EDGAR